Paper2736228
Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?
Al Jabaari B and 5 others. Br J Cancer, 1989. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy? Papers, record 2736228. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2736228
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Receptors, Mitogen | Major topic |
| Blotting, Western | |
| Female | |
| Humans | |
| Receptors, Interleukin-4 | |
| Reference Values |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2986752 | Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/2986752 | PubMed |
| 2 | 3884494 | The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies. | Immunology | 1985 | https://conductscience.org/library/papers/3884494 | PubMed |
| 3 | 2941517 | B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines. | J Exp Med | 1986 | https://conductscience.org/library/papers/2941517 | PubMed |
| 4 | 6977612 | Identification of a T cell-derived b cell growth factor distinct from interleukin 2. | J Exp Med | 1982 | https://conductscience.org/library/papers/6977612 | PubMed |
| 5 | 6124802 | Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. | Lancet | 1982 | https://conductscience.org/library/papers/6124802 | PubMed |
| 6 | 6836304 | Radioactive labeling of antibody: a simple and efficient method. | Science | 1983 | https://conductscience.org/library/papers/6836304 | PubMed |
| 7 | 6308472 | Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. | Nature | 1983 | https://conductscience.org/library/papers/6308472 | PubMed |
| 8 | 6351725 | Cellular oncogenes and retroviruses. | Annu Rev Biochem | 1983 | https://conductscience.org/library/papers/6351725 | PubMed |
| 9 | 6605169 | Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. | Blood | 1983 | https://conductscience.org/library/papers/6605169 | PubMed |
| 10 | 6196380 | Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6196380 | PubMed |
| 11 | 3090545 | T-cell and mast cell lines respond to B-cell stimulatory factor 1. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3090545 | PubMed |
| 12 | 3017396 | Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3017396 | PubMed |
| 13 | 3098893 | B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. | J Exp Med | 1987 | https://conductscience.org/library/papers/3098893 | PubMed |
| 14 | 3798106 | Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. | Science | 1987 | https://conductscience.org/library/papers/3798106 | PubMed |
| 15 | 3493066 | Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. | Cancer Res | 1987 | https://conductscience.org/library/papers/3493066 | PubMed |
| 16 | 2438939 | Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? | Am J Pathol | 1987 | https://conductscience.org/library/papers/2438939 | PubMed |
| 17 | 3496417 | Characterization of the human B cell stimulatory factor 1 receptor. | J Exp Med | 1987 | https://conductscience.org/library/papers/3496417 | PubMed |
| 18 | 2440569 | Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. | Cancer Res | 1987 | https://conductscience.org/library/papers/2440569 | PubMed |
| 19 | 2822372 | Oncogenes in development. | Development | 1987 | https://conductscience.org/library/papers/2822372 | PubMed |
| 20 | 3668732 | Epidermal growth factor receptors in lung tumours. | J Pathol | 1987 | https://conductscience.org/library/papers/3668732 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15714203 | Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15714203 | PubMed |
| 8932345 | Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8932345 | PubMed |
| 8855966 | Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8855966 | PubMed |
| 8595155 | Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124). | Br J Cancer | 1996 | https://conductscience.org/library/papers/8595155 | PubMed |
| 8423237 | Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8423237 | PubMed |
| 2200499 | Tumour-associated upregulation of the IL-4 receptor complex. | Br J Cancer Suppl | 1990 | https://conductscience.org/library/papers/2200499 | PubMed |
| 2045128 | Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins. | Immunology | 1991 | https://conductscience.org/library/papers/2045128 | PubMed |
| 1911184 | Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1911184 | PubMed |
| 1419612 | Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1419612 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL4R | 3566 | PubTator's text mining | https://conductscience.org/library/genes/3566 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2736228
GET https://conductscience.org/api/papers/v1/2736228/references?page=2